Jane Henderson
Director of Finance/CFO bij APOGEE THERAPEUTICS, INC.
Vermogen: 4 M $ op 31-03-2024
Profiel
Jane P. Henderson is Chief Financial Officer bij Adagio Therapeutics, Inc., een Onafhankelijk Niet-Uitvoerend Bestuurder bij Akero Therapeutics, Inc., een Onafhankelijk Bestuurder bij IVERIC bio, Inc., een Onafhankelijk Bestuurder bij Sesen Bio, Inc. en een Secretaris & Penningmeester bij The EQUUS Foundation, Inc. Ze zetelt in de Raad van Bestuur van Akero Therapeutics, Inc., IVERIC bio, Inc. en Sesen Bio, Inc. Mevrouw Henderson was voorheen werkzaam als Chief Financial Officer bij Turnstone Biologics, Inc., als Chief Financial Officer & Senior Vice President bij Voyager Therapeutics, Inc., als Senior VP, Chief Financial & Business Officer bij Kolltan Pharmaceuticals, Inc., als Vice President-Business Development bij ISTA Pharmaceuticals, Inc., als CFO, Executive VP & Chief Business Officer bij Axerion Therapeutics, Inc., als CFO, Secretary, Chief Business Officer & EVP bij Panacos Pharmaceuticals, Inc., als Managing Director bij CIBC World Markets Corp. (oud), een Senior Vice President bij Lehman Brothers, Inc., een CFO & Head-Business Development bij Axerion Pharmaceuticals, Inc., een Managing Director bij Canadian Imperial Bank of Commerce, een Managing Director bij HSBC Holdings Plc /US Auto Finance Business/, een Managing Director-Investment Banking Division bij HSBC Securities (USA), Inc., en een Managing Director bij Salomon Brothers. Zij heeft haar doctoraal behaald aan de Duke University.
Bekende belangen in openbare bedrijven
Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
---|---|---|---|---|
01-03-2024 | 56 026 ( 0.13% ) | 4 M $ | 31-03-2024 | |
AKERO THERAPEUTICS, INC.
-.--% | 23-06-2023 | 0 ( -.--% ) | - $ | 31-03-2024 |
INVIVYD, INC.
-.--% | 27-03-2023 | 0 ( -.--% ) | - $ | 31-03-2024 |
Actieve functies van Jane Henderson
Bedrijven | Functie | Begin |
---|---|---|
AKERO THERAPEUTICS, INC. | Director/Board Member | 23-04-2019 |
APOGEE THERAPEUTICS, INC. | Director of Finance/CFO | 01-01-2023 |
Ventus Therapeutics U.S., Inc.
Ventus Therapeutics U.S., Inc. Medical DistributorsDistribution Services Ventus Therapeutics U.S., Inc. operates as a biotechnology company. The company is headquartered in Natick, MA. | Director/Board Member | 07-11-2021 |
The EQUUS Foundation, Inc.
The EQUUS Foundation, Inc. Agricultural Commodities/MillingProcess Industries The EQUUS Foundation, Inc. operates an animal welfare organization that cares for horses. The non-profit company is based in Westport, CT. | Corporate Secretary | - |
Dedman College of Humanities & Sciences | Director/Board Member | - |
Eerdere bekende functies van Jane Henderson
Bedrijven | Functie | Einde |
---|---|---|
IVERIC BIO, INC. | Director/Board Member | 11-07-2023 |
INVIVYD, INC. | Director of Finance/CFO | 01-11-2022 |
CARISMA THERAPEUTICS, INC. | Director/Board Member | 22-11-2021 |
TURNSTONE BIOLOGICS CORP. | Director of Finance/CFO | 01-12-2020 |
░░░░░░░ ░░░░░░░░░░░░░ ░░░░ | ░░░░░░░░ ░░ ░░░░░░░░░░░ | ░░░░░░░░░░ |
Opleiding van Jane Henderson
Duke University | Undergraduate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
Beursgenoteerde bedrijven | 7 |
---|---|
CANADIAN IMPERIAL BANK OF COMMERCE | Finance |
HSBC HOLDINGS PLC | Finance |
PANACOS PHARMACEUTICALS, INC. | Health Technology |
VOYAGER THERAPEUTICS, INC. | Health Technology |
AKERO THERAPEUTICS, INC. | Health Technology |
TURNSTONE BIOLOGICS CORP. | Health Technology |
INVIVYD, INC. | Health Technology |
Bedrijven in privébezit | 15 |
---|---|
Lehman Brothers, Inc.
Lehman Brothers, Inc. Investment Banks/BrokersFinance A subsidiary of Lehman Brothers Holdings, Inc., Lehman Brothers, Inc. is a broker/dealer headquartered in New York City. They provide global equity and fixed research. The equity research department covers more than 100 sectors. They use a fundamental, quantitative, strategic and tactical research approach. In addition to these Lehman has also developed special products, such as 10 uncommon values and 10 uncommon eurovalues. | Finance |
CIBC World Markets Corp. (Old)
CIBC World Markets Corp. (Old) Financial ConglomeratesFinance CIBC World Markets is a full-service investment bank headquartered in New York City. CIBC provides an internationally integrated research product through three primary strategies. In the US, the firm provides research coverage available in areas of focus, including technology, telecommunications, healthcare, energy, power generation and technology, financial institutions, consumer growth, real estate and media. In Canada, the firm offers the full spectrum of coverage for all of the sectors that form the TSE 300 Index. Their broad investment grade analysis of return bond Indices provides daily performance of the Canadian bond market. The sectors covered are: government of Canada bonds, provincial and municipal bonds and corporate bonds rated AAA/AA, A and BBB. Also available is a monthly ABS/MBS market report that provides information on ABS market conditions, market summary data and monthly performance reports on outstanding transactions. This report includes information about the MBS market, including key statistics on MBS spreads and prepayments. Another report contains MBS trading data, cash flows and other key data. A separate monthly Portfolio Valuation Report provides month end pricing for ABS and MBS transactions. Corporate debt research produces highly targeted credit analysis and research for investment grade and high yield debt securities. The corporate bond review covers bond market action, new issues, price/yield movements, rating changes, and buy/sell recommendations. The fixed-income research group produces actionable fundamental and technical analysis, strategies, products, and runs bond indexes and quantitative models relating specifically to fixed income markets, bond portfolios, and individual securities. CIBC provides risk management solutions to corporations, investors, financial institutions, and governments across all asset classes: interest rates, equities, credit, currency, and commodities. CIBC World Markets is a subsidiary of Canadian Imperial Bank of Commerce. | Finance |
ISTA Pharmaceuticals, Inc.
ISTA Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology ISTA Pharmaceuticals, Inc. was incorporated as Advanced Corneal Systems, Inc. in California in February 1992 to discover, develop, and market new remedies for diseases and conditions of the eye. In March 2000, the company changed its name to ISTA Pharmaceuticals, Inc. It reincorporated, in Delaware, in August 2000. BROMDAY, BEPREVE, ISTALOL, VITRASE, XIBROM (bromfenac ophthalmic solution), XIBROM, T-PRED, PROLENSA, BEPOSONE, BEPOMAX, ISTA, ISTA Pharmaceuticals, Inc. and the ISTA logo are its trademarks, either owned or under license. Ista is commercial-stage, multi-specialty pharmaceutical company, which develops, markets, and sells its own products in the United States and Puerto Rico. Its products are intended to treat allergy and serious diseases of the eye and include therapies for ocular inflammation and pain, glaucoma, dry eye, and ocular and nasal allergies. | Health Technology |
HSBC Securities (USA), Inc.
HSBC Securities (USA), Inc. Investment Banks/BrokersFinance Founded in 1969, HSBC Securities (U.S.A.) Inc. is an SEC-registered brokerage firm and registered futures commission merchant located in New York City. The firm is a wholly-owned subsidiary of HSBC North America Holdings, Inc. and their ultimate parent is HSBC Holdings Plc. (NYSE: HBC). HSBC Securities (U.S.A.) is a member of FINRA, the NYSE and the SIPC. Their securities and annuity products are provided by registered representatives and insurance agents of HSBC Securities (U.S.A.). In California, HSBC Securities (U.S.A.) conducts insurance business as HSBC Securities Insurance Services. Insurance products are offered through insurance agents of HSBC Insurance Agency (U.S.A.) Inc., a wholly-owned subsidiary of HSBC Bank U.S.A. NA and an indirectly wholly-owned subsidiary of HSBC Holdings plc. The company also engages in investment banking underwriting, dealing and brokering of debt and equity securities and futures contracts and is a primary dealer in U.S. Government and federal agency securities. | Finance |
Kolltan Pharmaceuticals, Inc.
Kolltan Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Kolltan Pharmaceuticals, Inc. engaged in the development of monoclonal antibody drugs. It focused on the discovery and development of novel antibody-based drugs targeting receptor tyrosine kinases (RTKs) for the treatment of cancer and other diseases. The company was founded by Arthur G. Altschul, Jr. and Joseph P. Schlessinger on November 16, 2007 and was headquartered in New Haven, CT. | Health Technology |
Renetx Bio, Inc.
Renetx Bio, Inc. BiotechnologyHealth Technology Renetx Bio, Inc. operates as a biotechnology company that develops disease modifying therapeutics. It offers Nogo Receptor and Cellular Prion Protein technology. The company was founded by Sylvia McBrinn and Stephen Strittmatter in 2009 and is headquartered in New Haven, CT. | Health Technology |
Salomon Brothers | Finance |
IVERIC bio, Inc.
IVERIC bio, Inc. Pharmaceuticals: GenericHealth Technology IVERIC bio, Inc. operates as a biopharmaceutical company. The firm engages in discovering, developing and commercializing novel therapeutics to treat ophthalmic diseases, with a focus on age-related and orphan retinal diseases. Its product candidates include Zimura and Gene Therapy. The company was founded by David R. Guyer and Samir Chandrakant Patel on January 5, 2007 and is headquartered in Parsippany, NJ. | Health Technology |
Sesen Bio, Inc.
Sesen Bio, Inc. Pharmaceuticals: MajorHealth Technology Sesen Bio, Inc. is a late-stage clinical company, which engages in the development of targeted fusion protein therapeutics. It offers Vicineum and Proxinium, which target tumor cell surface antigens that allow for rapid internalization into the targeted cancer cell and also have limited expression on normal cells. The company was founded by Reza Dana, K. Christopher Garcia, Gregory L. Verdine, Casey T. Weaver, and K. Dane Wittrup on February 25, 2008 and is headquartered in Cambridge, MA. | Health Technology |
HSBC Holdings Plc /US Auto Finance Business/ | Finance |
The EQUUS Foundation, Inc.
The EQUUS Foundation, Inc. Agricultural Commodities/MillingProcess Industries The EQUUS Foundation, Inc. operates an animal welfare organization that cares for horses. The non-profit company is based in Westport, CT. | Process Industries |
Axerion Pharmaceuticals, Inc. | |
Ventus Therapeutics, Inc.
Ventus Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Ventus Therapeutics, Inc. operates as a biopharmaceutical company. It focuses in developing novel small molecule medicines that target the innate immune system to treat autoimmune diseases, inflammatory diseases and cancer. The company was founded by Hao Wu, Richard Flavell, Judy Lieberman, Thomas Tuschl, and Feng Shao and is headquartered in Montreal, Canada. | Health Technology |
Ventus Therapeutics U.S., Inc.
Ventus Therapeutics U.S., Inc. Medical DistributorsDistribution Services Ventus Therapeutics U.S., Inc. operates as a biotechnology company. The company is headquartered in Natick, MA. | Distribution Services |
Apogee Therapeutics, Inc. |